Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
• The global Inactivated Poultry Vaccine market was valued at US$ 3546 Million in 2024
• It is estimated to expand at a CAGR of 4.20% % from 2024 to 2031
• The global Inactivated Poultry Vaccine market is expected to reach the value of US$ 4621 Million by the end of 2031
Inactivated Poultry Vaccine Market Overview
Inactivated poultry vaccines belong to a class of preventative biologics called "subunit/inactivated virus vaccines." They contain only parts of the virus rather than the entire pathogen. These components are isolated from disease cells and weakened or killed before use in humans and animals so they won"t cause illness but still trigger immune responses to protect against subsequent exposure to live viruses.
The global inactivated poultry vaccine market represents one segment within the broader animal vaccines industry that includes subcategories based on species and diseases targeted. This particular subset serves as a critical component in global efforts to manage avian influenza outbreaks caused by deadly H5N8 and H5N6 strains spreading rapidly across continents posing serious threats to human and animal health. To combat this devastating threat, governments around the globe encourage research & development (R&D) investment in effective vaccines adaptable to different regions and birds breeds while companies strive to meet escalating consumer needs driving accelerated evolution towards safer, stronger formulations guaranteeing enhanced protection versus emerging virulent strains. Ongoing studies explore advanced manufacturing techniques and adjuvants promising increased potency and longevity, expanding opportunities for market expansion beyond current offerings leveraged mainly in Asian-Pacific countries where demand remains consistently strong. Suppliers maintain competitive edge via continuous innovation refining production processes ensuring quality performance under diverse conditions extending lifespans maximizing efficiency minimizing waste amidst persistent supply chain complexities faced daily by every participant operating within volatile environments rife with unpredictability testing resilience throughout extended value chains impacting everyone along each step necessitating flexibility adaptability sustaining viability securing future success.
This report studies and analyses global Inactivated Poultry Vaccine status and future trends, helping the client to determine the Inactivated Poultry Vaccine market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Inactivated Poultry Vaccine. It provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. To assess the competitive environment within the market, including supplier revenue, market share, and company profiles.
Inactivated Poultry Vaccine Market Key Takeaways
(1) Global Inactivated Poultry Vaccine market size, history data 2020-2024 , and forecast data 2024 -2031, (US$ million) & (K Units)
(2) Global Inactivated Poultry Vaccine sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(3) China Inactivated Poultry Vaccine sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(4) Global Inactivated Poultry Vaccine key consuming regions, consumption quantity, consumption value, and demand structure
(5) Global Inactivated Poultry Vaccine key producing regions, capacity, production, and year-over-year growth
(6) Inactivated Poultry Vaccine industry chains, upstream, midstream, and downstream
Inactivated Poultry Vaccine Market: Key Players
The competitive landscape of the Inactivated Poultry Vaccine Market offers a comprehensive analysis of key players. It includes insights such as company overviews, financial performance, revenue generation, market potential, research and development investments, new market strategies, regional presence, strengths and weaknesses, product launches, product range, and application leadership. These data points specifically pertain to the companies' activities and focus within the Inactivated Poultry Vaccine Market. Some of the major players operating in the Inactivated Poultry Vaccine Market are:
- Zoetis
- Merck Animal Health
- Boehringer Ingelheim
- Elanco Animal Health
- Phibro Animal Health
- Virbac
- Hipra
- Venkys
- Biovet
- Ringpu Biology
- Ceva Corporate
- KM Biologics
- Vaxxinova
- Japfa Comfeed Indonesia
- Nisseiken
Market IntelliX's study on the Inactivated Poultry Vaccine market offers information divided into important segments — type, applications, end-use, and region. This report provides comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Inactivated Poultry Vaccine Market by Type [Analysis by Value from 2020 to 2031]:
- Liquid Vaccines
- Freeze-Dried Vaccines
Inactivated Poultry Vaccine Market by Application [Analysis by Value from 2020 to 2031]:
- Avian Encephalomyelitis
- Chicken Anaemia
- Egg Drop Syndrome
- Others
Inactivated Poultry Vaccine Market by Region [Analysis by Value from 2020 to 2031]:
- North America (United States, Canada and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Spain etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
- South America (Brazil, Argentina and Colombia etc.)
- Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
Inactivated Poultry Vaccine Market Report Includes:
Chapter 1: To describe Inactivated Poultry Vaccine product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Inactivated Poultry Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024
Chapter 3: China Inactivated Poultry Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024
Chapter 4: Global key producing regions of Inactivated Poultry Vaccine , percent & CAGR, 2020 - 2031
Chapter 5: Inactivated Poultry Vaccine industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, and gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Inactivated Poultry Vaccine Definition
1.2 Global Inactivated Poultry Vaccine Market Size and Forecast
1.2.1 By Consumption Value, Global Inactivated Poultry Vaccine Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Inactivated Poultry Vaccine Market Size, 2020-2031
1.2.3 Global Inactivated Poultry Vaccine Average Selling Price (ASP), 2020-2031
1.3 China Inactivated Poultry Vaccine Market Size and Forecast
1.3.1 By Consumption Value, China Inactivated Poultry Vaccine Market Size, 2020-2031
1.3.2 By Sales Quantity, China Inactivated Poultry Vaccine Market Size, 2020-2031
1.3.3 China Inactivated Poultry Vaccine Average Selling Price (ASP), 2020-2031
1.4 Share of China Inactivated Poultry Vaccine Market with Respect to the Global Market
1.4.1 By Consumption Value, China Inactivated Poultry Vaccine Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Inactivated Poultry Vaccine Market Share in Global, 2020-2031
1.4.3 Inactivated Poultry Vaccine Market Size: China VS Global, 2020-2031
1.5 Inactivated Poultry Vaccine Market Dynamics
1.5.1 Inactivated Poultry Vaccine Market Drivers
1.5.2 Inactivated Poultry Vaccine Market Restraints
1.5.3 Inactivated Poultry Vaccine Industry Trends
1.5.4 Inactivated Poultry Vaccine Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Inactivated Poultry Vaccine, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Inactivated Poultry Vaccine, Global Market Share by Company, 2020-2025
2.3 Inactivated Poultry Vaccine Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Inactivated Poultry Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Inactivated Poultry Vaccine Concentration Ratio
2.6 Global Inactivated Poultry Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Inactivated Poultry Vaccine Manufacturers Product Type
2.8 Head Office and Inactivated Poultry Vaccine Production Site of Key Manufacturer
2.9 Inactivated Poultry Vaccine Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Inactivated Poultry Vaccine, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Inactivated Poultry Vaccine, China Market Share by Company, 2020-2025
3.3 China Inactivated Poultry Vaccine Inactivated Poultry Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Inactivated Poultry Vaccine Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Inactivated Poultry Vaccine Capacity by Region
4.3 Global Inactivated Poultry Vaccine Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Inactivated Poultry Vaccine Production by Region, 2020-2031
4.5 Global Inactivated Poultry Vaccine Production Market Share & Forecast by Region, 2020-2031
5 Industry Chain Analysis
5.1 Inactivated Poultry Vaccine Industry Chain
5.2 Inactivated Poultry Vaccine Upstream Analysis
5.2.1 Inactivated Poultry Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Inactivated Poultry Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Inactivated Poultry Vaccine Production Mode
5.6 Inactivated Poultry Vaccine Procurement Model
5.7 Inactivated Poultry Vaccine Industry Sales Model and Sales Channels
5.7.1 Inactivated Poultry Vaccine Sales Model
5.7.2 Inactivated Poultry Vaccine Typical Distributors
6 Sights by Product Type
6.1 Inactivated Poultry Vaccine Classification
6.1.1 Liquid Vaccines
6.1.2 Freeze-Dried Vaccines
6.2 by Type, Global Inactivated Poultry Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Inactivated Poultry Vaccine Consumption Value, 2020-2031
6.4 by Type, Global Inactivated Poultry Vaccine Sales Quantity, 2020-2031
6.5 by Type, Global Inactivated Poultry Vaccine Average Selling Price (ASP), 2020-2031
7 Sights by Application
7.1 Inactivated Poultry Vaccine Segment by Application
7.1.1 Avian Encephalomyelitis
7.1.2 Chicken Anaemia
7.1.3 Egg Drop Syndrome
7.1.4 Others
7.2 by Application, Global Inactivated Poultry Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Inactivated Poultry Vaccine Consumption Value, 2020-2031
7.4 by Application, Global Inactivated Poultry Vaccine Sales Quantity, 2020-2031
7.5 by Application, Global Inactivated Poultry Vaccine Price, 2020-2031
8 Sales Sights by Region
8.1 By Region, Global Inactivated Poultry Vaccine Consumption Value, 2020 VS 2024 VS 2031
8.2 By Region, Global Inactivated Poultry Vaccine Consumption Value, 2020-2031
8.3 By Region, Global Inactivated Poultry Vaccine Sales Quantity, 2020-2031
8.4 North America
8.4.1 North America Inactivated Poultry Vaccine Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Inactivated Poultry Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Inactivated Poultry Vaccine Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Inactivated Poultry Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Inactivated Poultry Vaccine Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Inactivated Poultry Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Inactivated Poultry Vaccine Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Inactivated Poultry Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Inactivated Poultry Vaccine Market Size & CAGR, 2020 VS 2024 VS 2031
9.2 By Country, Global Inactivated Poultry Vaccine Consumption Value, 2020-2031
9.3 By Country, Global Inactivated Poultry Vaccine Sales Quantity, 2020-2031
9.4 United States
9.4.1 United States Inactivated Poultry Vaccine Market Size, 2020-2031
9.4.2 by Type, United States Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.4.3 by Application, United States Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Inactivated Poultry Vaccine Market Size, 2020-2031
9.5.2 by Type, Europe Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.5.3 by Application, Europe Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.6 China
9.6.1 China Inactivated Poultry Vaccine Market Size, 2020-2031
9.6.2 by Type, China Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.6.3 by Application, China Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Inactivated Poultry Vaccine Market Size, 2020-2031
9.7.2 by Type, Japan Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.7.3 by Application, Japan Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Inactivated Poultry Vaccine Market Size, 2020-2031
9.8.2 by Type, South Korea Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.8.3 by Application, South Korea Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Inactivated Poultry Vaccine Market Size, 2020-2031
9.9.2 by Type, Southeast Asia Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.9.3 by Application, Southeast Asia Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.10 India
9.10.1 India Inactivated Poultry Vaccine Market Size, 2020-2031
9.10.2 by Type, India Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.10.3 by Application, India Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Inactivated Poultry Vaccine Market Size, 2020-2031
9.11.2 by Type, Middle East & Africa Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
9.11.3 by Application, Middle East & Africa Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
10 Manufacturers Profile
10.1 Zoetis
10.1.1 Zoetis Company Information, Head Office, Market Area, and Industry Position
10.1.2 Zoetis Inactivated Poultry Vaccine Models, Specifications, and Application
10.1.3 Zoetis Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Zoetis Company Profile and Main Business
10.1.5 Zoetis Recent Developments
10.2 Merck Animal Health
10.2.1 Merck Animal Health Company Information, Head Office, Market Area, and Industry Position
10.2.2 Merck Animal Health Inactivated Poultry Vaccine Models, Specifications, and Application
10.2.3 Merck Animal Health Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Merck Animal Health Company Profile and Main Business
10.2.5 Merck Animal Health Recent Developments
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
10.3.2 Boehringer Ingelheim Inactivated Poultry Vaccine Models, Specifications, and Application
10.3.3 Boehringer Ingelheim Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Boehringer Ingelheim Company Profile and Main Business
10.3.5 Boehringer Ingelheim Recent Developments
10.4 Elanco Animal Health
10.4.1 Elanco Animal Health Company Information, Head Office, Market Area, and Industry Position
10.4.2 Elanco Animal Health Inactivated Poultry Vaccine Models, Specifications, and Application
10.4.3 Elanco Animal Health Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Elanco Animal Health Company Profile and Main Business
10.4.5 Elanco Animal Health Recent Developments
10.5 Phibro Animal Health
10.5.1 Phibro Animal Health Company Information, Head Office, Market Area, and Industry Position
10.5.2 Phibro Animal Health Inactivated Poultry Vaccine Models, Specifications, and Application
10.5.3 Phibro Animal Health Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.5.4 Phibro Animal Health Company Profile and Main Business
10.5.5 Phibro Animal Health Recent Developments
10.6 Virbac
10.6.1 Virbac Company Information, Head Office, Market Area, and Industry Position
10.6.2 Virbac Inactivated Poultry Vaccine Models, Specifications, and Application
10.6.3 Virbac Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Virbac Company Profile and Main Business
10.6.5 Virbac Recent Developments
10.7 Hipra
10.7.1 Hipra Company Information, Head Office, Market Area, and Industry Position
10.7.2 Hipra Inactivated Poultry Vaccine Models, Specifications, and Application
10.7.3 Hipra Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.7.4 Hipra Company Profile and Main Business
10.7.5 Hipra Recent Developments
10.8 Venkys
10.8.1 Venkys Company Information, Head Office, Market Area, and Industry Position
10.8.2 Venkys Inactivated Poultry Vaccine Models, Specifications, and Application
10.8.3 Venkys Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.8.4 Venkys Company Profile and Main Business
10.8.5 Venkys Recent Developments
10.9 Biovet
10.9.1 Biovet Company Information, Head Office, Market Area, and Industry Position
10.9.2 Biovet Inactivated Poultry Vaccine Models, Specifications, and Application
10.9.3 Biovet Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Biovet Company Profile and Main Business
10.9.5 Biovet Recent Developments
10.10 Ringpu Biology
10.10.1 Ringpu Biology Company Information, Head Office, Market Area, and Industry Position
10.10.2 Ringpu Biology Inactivated Poultry Vaccine Models, Specifications, and Application
10.10.3 Ringpu Biology Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.10.4 Ringpu Biology Company Profile and Main Business
10.10.5 Ringpu Biology Recent Developments
10.11 Ceva Corporate
10.11.1 Ceva Corporate Company Information, Head Office, Market Area, and Industry Position
10.11.2 Ceva Corporate Inactivated Poultry Vaccine Models, Specifications, and Application
10.11.3 Ceva Corporate Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.11.4 Ceva Corporate Company Profile and Main Business
10.11.5 Ceva Corporate Recent Developments
10.12 KM Biologics
10.12.1 KM Biologics Company Information, Head Office, Market Area, and Industry Position
10.12.2 KM Biologics Inactivated Poultry Vaccine Models, Specifications, and Application
10.12.3 KM Biologics Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.12.4 KM Biologics Company Profile and Main Business
10.12.5 KM Biologics Recent Developments
10.13 Vaxxinova
10.13.1 Vaxxinova Company Information, Head Office, Market Area, and Industry Position
10.13.2 Vaxxinova Inactivated Poultry Vaccine Models, Specifications, and Application
10.13.3 Vaxxinova Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.13.4 Vaxxinova Company Profile and Main Business
10.13.5 Vaxxinova Recent Developments
10.14 Japfa Comfeed Indonesia
10.14.1 Japfa Comfeed Indonesia Company Information, Head Office, Market Area, and Industry Position
10.14.2 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Models, Specifications, and Application
10.14.3 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.14.4 Japfa Comfeed Indonesia Company Profile and Main Business
10.14.5 Japfa Comfeed Indonesia Recent Developments
10.15 Nisseiken
10.15.1 Nisseiken Company Information, Head Office, Market Area, and Industry Position
10.15.2 Nisseiken Inactivated Poultry Vaccine Models, Specifications, and Application
10.15.3 Nisseiken Inactivated Poultry Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.15.4 Nisseiken Company Profile and Main Business
10.15.5 Nisseiken Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Inactivated Poultry Vaccine Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Inactivated Poultry Vaccine Market Restraints
Table 3. Inactivated Poultry Vaccine Market Trends
Table 4. Inactivated Poultry Vaccine Industry Policy
Table 5. Global Inactivated Poultry Vaccine Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 6. Global Inactivated Poultry Vaccine Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 7. Global Inactivated Poultry Vaccine Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024
Table 8. Global Inactivated Poultry Vaccine Sales Quantity by Company, 2020-2025, Ranked by Data of 2024
Table 9. Global Inactivated Poultry Vaccine Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)
Table 10. Global Inactivated Poultry Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Inactivated Poultry Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Inactivated Poultry Vaccine Manufacturers Product Type
Table 13. Head Office and Inactivated Poultry Vaccine Production Site of Key Manufacturer
Table 14. Inactivated Poultry Vaccine Capacity of Major Manufacturers and Future Plan
Table 15. China Inactivated Poultry Vaccine Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 16. China Inactivated Poultry Vaccine Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 17. China Inactivated Poultry Vaccine Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024
Table 18. China Inactivated Poultry Vaccine Sales Quantity by Company, 2020-2025, Ranked by Data of 2024
Table 19. Global Inactivated Poultry Vaccine Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)
Table 20. Global Inactivated Poultry Vaccine Production by Region, 2020-2025, (K Units)
Table 21. Global Inactivated Poultry Vaccine Production Forecast by Region, 2026-2031, (K Units)
Table 22. Global Key Players of Inactivated Poultry Vaccine Upstream (Raw Materials)
Table 23. Global Inactivated Poultry Vaccine Typical Customers
Table 24. Inactivated Poultry Vaccine Typical Distributors
Table 25. by Type, Global Inactivated Poultry Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 26. by Application, Global Inactivated Poultry Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 27. By Region, Global Inactivated Poultry Vaccine Consumption Value, 2020 VS 2024 VS 2031, US$ Million
Table 28. By Region, Global Inactivated Poultry Vaccine Consumption Value, 2020-2031, US$ Million
Table 29. By Region, Global Inactivated Poultry Vaccine Sales Quantity, 2020-2031, (K Units)
Table 30. By Country, Global Inactivated Poultry Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 31. By Country, Global Inactivated Poultry Vaccine Consumption Value, 2020-2031, US$ Million
Table 32. By Country, Global Inactivated Poultry Vaccine Consumption Value Market Share, 2020-2031
Table 33. By Country, Global Inactivated Poultry Vaccine Sales Quantity, 2020-2031, (K Units)
Table 34. By Country, Global Inactivated Poultry Vaccine Sales Quantity Market Share, 2020-2031
Table 35. Zoetis Company Information, Head Office, Market Area, and Industry Position
Table 36. Zoetis Inactivated Poultry Vaccine Models, Specifications, and Application
Table 37. Zoetis Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 38. Zoetis Company Profile and Main Business
Table 39. Zoetis Recent Developments
Table 40. Merck Animal Health Company Information, Head Office, Market Area, and Industry Position
Table 41. Merck Animal Health Inactivated Poultry Vaccine Models, Specifications, and Application
Table 42. Merck Animal Health Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 43. Merck Animal Health Company Profile and Main Business
Table 44. Merck Animal Health Recent Developments
Table 45. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
Table 46. Boehringer Ingelheim Inactivated Poultry Vaccine Models, Specifications, and Application
Table 47. Boehringer Ingelheim Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 48. Boehringer Ingelheim Company Profile and Main Business
Table 49. Boehringer Ingelheim Recent Developments
Table 50. Elanco Animal Health Company Information, Head Office, Market Area, and Industry Position
Table 51. Elanco Animal Health Inactivated Poultry Vaccine Models, Specifications, and Application
Table 52. Elanco Animal Health Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 53. Elanco Animal Health Company Profile and Main Business
Table 54. Elanco Animal Health Recent Developments
Table 55. Phibro Animal Health Company Information, Head Office, Market Area, and Industry Position
Table 56. Phibro Animal Health Inactivated Poultry Vaccine Models, Specifications, and Application
Table 57. Phibro Animal Health Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 58. Phibro Animal Health Company Profile and Main Business
Table 59. Phibro Animal Health Recent Developments
Table 60. Virbac Company Information, Head Office, Market Area, and Industry Position
Table 61. Virbac Inactivated Poultry Vaccine Models, Specifications, and Application
Table 62. Virbac Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 63. Virbac Company Profile and Main Business
Table 64. Virbac Recent Developments
Table 65. Hipra Company Information, Head Office, Market Area, and Industry Position
Table 66. Hipra Inactivated Poultry Vaccine Models, Specifications, and Application
Table 67. Hipra Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 68. Hipra Company Profile and Main Business
Table 69. Hipra Recent Developments
Table 70. Venkys Company Information, Head Office, Market Area, and Industry Position
Table 71. Venkys Inactivated Poultry Vaccine Models, Specifications, and Application
Table 72. Venkys Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 73. Venkys Company Profile and Main Business
Table 74. Venkys Recent Developments
Table 75. Biovet Company Information, Head Office, Market Area, and Industry Position
Table 76. Biovet Inactivated Poultry Vaccine Models, Specifications, and Application
Table 77. Biovet Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 78. Biovet Company Profile and Main Business
Table 79. Biovet Recent Developments
Table 80. Ringpu Biology Company Information, Head Office, Market Area, and Industry Position
Table 81. Ringpu Biology Inactivated Poultry Vaccine Models, Specifications, and Application
Table 82. Ringpu Biology Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 83. Ringpu Biology Company Profile and Main Business
Table 84. Ringpu Biology Recent Developments
Table 85. Ceva Corporate Company Information, Head Office, Market Area, and Industry Position
Table 86. Ceva Corporate Inactivated Poultry Vaccine Models, Specifications, and Application
Table 87. Ceva Corporate Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 88. Ceva Corporate Company Profile and Main Business
Table 89. Ceva Corporate Recent Developments
Table 90. KM Biologics Company Information, Head Office, Market Area, and Industry Position
Table 91. KM Biologics Inactivated Poultry Vaccine Models, Specifications, and Application
Table 92. KM Biologics Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 93. KM Biologics Company Profile and Main Business
Table 94. KM Biologics Recent Developments
Table 95. Vaxxinova Company Information, Head Office, Market Area, and Industry Position
Table 96. Vaxxinova Inactivated Poultry Vaccine Models, Specifications, and Application
Table 97. Vaxxinova Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 98. Vaxxinova Company Profile and Main Business
Table 99. Vaxxinova Recent Developments
Table 100. Japfa Comfeed Indonesia Company Information, Head Office, Market Area, and Industry Position
Table 101. Japfa Comfeed Indonesia Inactivated Poultry Vaccine Models, Specifications, and Application
Table 102. Japfa Comfeed Indonesia Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 103. Japfa Comfeed Indonesia Company Profile and Main Business
Table 104. Japfa Comfeed Indonesia Recent Developments
Table 105. Nisseiken Company Information, Head Office, Market Area, and Industry Position
Table 106. Nisseiken Inactivated Poultry Vaccine Models, Specifications, and Application
Table 107. Nisseiken Inactivated Poultry Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 108. Nisseiken Company Profile and Main Business
Table 109. Nisseiken Recent Developments
List of Figures
Figure 1. Inactivated Poultry Vaccine Picture
Figure 2. Global Inactivated Poultry Vaccine Consumption Value, (US$ million) & (2020-2031)
Figure 3. Global Inactivated Poultry Vaccine Sales Quantity, (K Units) & (2020-2031)
Figure 4. Global Inactivated Poultry Vaccine Average Selling Price (ASP), (2020-2031) & (US$/Unit)
Figure 5. China Inactivated Poultry Vaccine Consumption Value, (US$ million) & (2020-2031)
Figure 6. China Inactivated Poultry Vaccine Sales Quantity (K Units) & (2020-2031)
Figure 7. China Inactivated Poultry Vaccine Average Selling Price (ASP), (US$/Unit) & (2020-2031)
Figure 8. By Consumption Value, China Inactivated Poultry Vaccine Market Share of Global, 2020-2031
Figure 9. By Sales Quantity, China Inactivated Poultry Vaccine Market Share of Global, 2020-2031
Figure 10. Global Inactivated Poultry Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 11. China Inactivated Poultry Vaccine Key Participants, Market Share, 2024
Figure 12. Global Inactivated Poultry Vaccine Capacity, Production and Capacity Utilization, 2020-2031
Figure 13. Global Inactivated Poultry Vaccine Capacity Market Share by Region, 2024 VS 2031
Figure 14. Global Inactivated Poultry Vaccine Production Market Share & Forecast by Region, 2020-2031
Figure 15. Inactivated Poultry Vaccine Industry Chain
Figure 16. Inactivated Poultry Vaccine Procurement Model
Figure 17. Inactivated Poultry Vaccine Sales Model
Figure 18. Inactivated Poultry Vaccine Sales Channels, Direct Sales, and Distribution
Figure 19. Liquid Vaccines
Figure 20. Freeze-Dried Vaccines
Figure 21. by Type, Global Inactivated Poultry Vaccine Consumption Value, 2020-2031, US$ Million
Figure 22. by Type, Global Inactivated Poultry Vaccine Consumption Value Market Share, 2020-2031
Figure 23. by Type, Global Inactivated Poultry Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 24. by Type, Global Inactivated Poultry Vaccine Sales Quantity Market Share, 2020-2031
Figure 25. by Type, Global Inactivated Poultry Vaccine Average Selling Price (ASP), 2020-2031, (US$/Unit)
Figure 26. Avian Encephalomyelitis
Figure 27. Chicken Anaemia
Figure 28. Egg Drop Syndrome
Figure 29. Others
Figure 30. by Application, Global Inactivated Poultry Vaccine Consumption Value, 2020-2031, US$ Million
Figure 31. by Application, Global Inactivated Poultry Vaccine Revenue Market Share, 2020-2031
Figure 32. by Application, Global Inactivated Poultry Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 33. by Application, Global Inactivated Poultry Vaccine Sales Quantity Market Share, 2020-2031
Figure 34. by Application, Global Inactivated Poultry Vaccine Price, 2020-2031, (US$/Unit)
Figure 35. By Region, Global Inactivated Poultry Vaccine Consumption Value Market Share, 2020-2031
Figure 36. By Region, Global Inactivated Poultry Vaccine Sales Quantity Market Share, 2020-2031
Figure 37. North America Inactivated Poultry Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 38. By Country, North America Inactivated Poultry Vaccine Consumption Value Market Share, 2024
Figure 39. Europe Inactivated Poultry Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 40. By Country, Europe Inactivated Poultry Vaccine Consumption Value Market Share, 2024
Figure 41. Asia Pacific Inactivated Poultry Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 42. By Country/Region, Asia Pacific Inactivated Poultry Vaccine Consumption Value Market Share, 2024
Figure 43. South America Inactivated Poultry Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 44. By Country, South America Inactivated Poultry Vaccine Consumption Value Market Share, 2024
Figure 45. Middle East & Africa Inactivated Poultry Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 46. United States Inactivated Poultry Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 47. by Type, United States Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 48. by Application, United States Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 49. Europe Inactivated Poultry Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 50. by Type, Europe Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 51. by Application, Europe Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 52. China Inactivated Poultry Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 53. by Type, China Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 54. by Application, China Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 55. Japan Inactivated Poultry Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 56. by Type, Japan Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 57. by Application, Japan Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 58. South Korea Inactivated Poultry Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 59. by Type, South Korea Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 60. by Application, South Korea Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 61. Southeast Asia Inactivated Poultry Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 62. by Type, Southeast Asia Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 63. by Application, Southeast Asia Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 64. India Inactivated Poultry Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 65. by Type, India Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 66. by Application, India Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 67. Middle East & Africa Inactivated Poultry Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 68. by Type, Middle East & Africa Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 69. by Application, Middle East & Africa Inactivated Poultry Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up Approaches
Figure 73. Top-down Approaches
Research Methodology:
Inactivated Poultry Vaccine Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|